A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

June 30, 2008

Conditions
Atrial Fibrillation
Interventions
DRUG

propafenone; flecainide; sotalol; dofetilide

Above drugs prescribed per established guidelines for treatment of AF

DEVICE

Radiofrequency catheter ablation

A special catheter that delivers radiofrequency (heat) energy is advanced into the heart and used to destroy small areas of heart tissue responsible for causing atrial fibrillation. All catheters / devices used in the study are FDA approved for human use and currently being used to perform the AF ablation procedure in the United Sates.

Trial Locations (2)

19104

Hospital of the University of Pennsylvania, Philadelphia

Presbyterian Medical Center, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT00408200 - A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation | Biotech Hunter | Biotech Hunter